NASDAQ:RAPT RAPT Therapeutics (RAPT) Earnings Date, Estimates & Call Transcripts $20.35 +0.30 (+1.50%) (As of 05/26/2023 04:00 PM ET) Add Compare Share Share Today's Range$19.98▼$20.4850-Day Range$16.06▼$21.3452-Week Range$12.85▼$32.45Volume168,900 shsAverage Volume439,286 shsMarket Capitalization$699.02 millionP/E RatioN/ADividend YieldN/APrice Target$41.22 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Earnings Summary Upcoming Earnings DateAug. 10EstimatedActual EPS (Mar. 14) -$0.64 Beat By $0.03 Consensus EPS (Mar. 14) -$0.67 Last Year's Q1 EPS (3/10/2022) -$0.61Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRAPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RAPT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.RAPT Therapeutics Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20234($0.91)($0.51)($0.70)Q2 20234($1.00)($0.54)($0.75)Q3 20234($1.01)($0.57)($0.78)Q4 20234($1.09)($0.54)($0.81)FY 202316($4.01)($2.16)($3.05)Q1 20241($0.88)($0.88)($0.88)Q2 20241($0.91)($0.91)($0.91)Q3 20241($1.00)($1.00)($1.00)Q4 20241($1.06)($1.06)($1.06)FY 20244($3.85)($3.85)($3.85) Get RAPT Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for RAPT and its competitors with MarketBeat's FREE daily newsletter. RAPT Earnings Date and InformationRAPT Therapeutics last issued its quarterly earnings data on March 14th, 2023. The reported ($0.64) earnings per share for the quarter, beating the consensus estimate of ($0.67) by $0.03. RAPT Therapeutics has generated ($2.65) earnings per share over the last year (($2.65) diluted earnings per share). Earnings for RAPT Therapeutics are expected to decrease in the coming year, from ($3.18) to ($3.42) per share. RAPT Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.Read More RAPT Therapeutics Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/10/2023(Estimated) 3/14/2023Q4 2022($0.67)($0.64)+$0.03($0.64)11/10/2022Q3 2022($0.65)($0.63)+$0.02($0.63)8/11/2022Q2 2022($0.75)($0.62)+$0.13($0.62)$0.40 million$0.89 million5/11/2022Q1 2022($0.66)($0.69)($0.03)($0.69)$0.40 million$0.64 million3/10/2022Q4 2021($0.66)($0.61)+$0.05($0.61)$1.50 million$0.76 million11/10/20219/30/2021($0.62)($0.63)($0.01)($0.63)$1.45 million$0.97 million8/11/20216/30/2021($0.68)($0.63)+$0.05($0.63)$1.43 million$0.87 million5/11/20213/31/2021($0.60)($0.66)($0.06)($0.66)$1.70 million$1.22 million3/11/202112/31/2020($0.58)($0.52)+$0.06($0.52)$2.05 million$1.30 million11/15/20209/30/2020($0.56)($0.60)($0.04)($0.60)$2.50 million$1.53 million8/13/2020Q2 2020($0.5770)($0.5090)+$0.0680($0.51)$2.50 million$1.28 million5/14/20203/31/2020($0.43)($0.56)($0.13)($0.56)$2.50 million$0.94 million3/30/202012/31/2019($0.74)($0.82)($0.08)($0.87)12/11/2019Q3 2019($6.15)($12.41)($6.26)($12.41)RAPT Therapeutics Earnings - Frequently Asked Questions When is RAPT Therapeutics's earnings date? RAPT Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on RAPT's earnings history. Did RAPT Therapeutics beat their earnings estimates last quarter? In the previous quarter, RAPT Therapeutics (NASDAQ:RAPT) reported ($0.64) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.67) by $0.03. Learn more on analysts' earnings estimate vs. RAPT's actual earnings. How much revenue does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded annual revenue of $1.53 million. How much profit does RAPT Therapeutics generate each year? RAPT Therapeutics (NASDAQ:RAPT) has a recorded net income of -$83.84 million. RAPT has generated -$2.65 earnings per share over the last four quarters. What is RAPT Therapeutics's EPS forecast for next year? RAPT Therapeutics's earnings are expected to decrease from ($3.18) per share to ($3.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Intercept Pharmaceuticals Earnings Results Lyell Immunopharma Earnings Results Terns Pharmaceuticals Earnings Results Arcturus Therapeutics Earnings Results Seres Therapeutics Earnings Results Pharming Group Earnings Results Theravance Biopharma Earnings Results ARS Pharmaceuticals Earnings Results Disc Medicine Opco Earnings Results Harrow Health Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Costco's Earnings Call Reassure Economists, Recession Cancelled Best Buy's Comeback Is Still At Play, Earnings Call For Patience 2 Energy Mid-Caps Expected To Post Monster Earnings GrowthPetCo Management Getting it Right? Earnings Beat Says YesAutoZone Reports Earnings Beat, Shares Fall, Outlook PositiveCan Ryanair Stock Fly Above Resistance Levels, What Earnings ShowAnalyst Flags Concerns About P&G Growth Despite Earnings Beat This page (NASDAQ:RAPT) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RAPT Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.